Fresenius Medical Care AG & Co. KGaA agreed to pay about $231 million to resolve U.S. Department of Justice (DoJ) and SEC investigations into violations of the Foreign Corrupt Practices Act. According to Fresenius' admissions, it paid bribes between 2007 and 2016 to publicly employed health or government officials to obtain or retain business in several countries.